Validity of(-)-[3H]-CGP 12177A as a radioligand for the 'putative β4-adrenoceptor' in rat atrium

British Journal of Pharmacology

Volumn 123, Issue 3, 1998, Pages 371-380

  Sarsero, Doreen ^a   Molenaar, Peter ^a   Kaumann, Alberto J ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

1 adrenoceptor; 'putative 4 adrenoceptor'; ( ) 3h CGP 12177A; ( ) CGP 12177A; ( ) R0363; Atypical adrenoceptors; Catecholamines; Non conventional partial agonists; Rat atrium

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 1 (3,4 DIHYDROXYPHENOXY) 3 (3,4 DIMETHOXYPHENETHYLAMINO) 2 PROPANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [(2 HYDROXY 2 PHENYLETHYL)AMINO]ETHOXY]PHENYLACETIC ACID; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; 8 AMINO 7 IODO 1,4 BENZODIOXAN 5 CARBOXYLIC ACID 1 BUTYL 4 PIPERIDINYLMETHYL ESTER; [[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER; ADRENALIN; ATROPINE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUPRANOLOL; CARAZOLOL; CYANOPINDOLOL; HISTAMINE; ISOPRENALINE; NORADRENALIN; PHENTOLAMINE; PINDOLOL; PROPRANOLOL; RADIOLIGAND; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; PROPANOLAMINE DERIVATIVE; TRITIUM;

ANIMAL TISSUE; ARTICLE; DRUG RECEPTOR BINDING; FEMALE; HEART ATRIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BINDING COMPETITION; IN VITRO STUDY; KINETICS; METABOLISM; RADIOASSAY; SPRAGUE DAWLEY RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; BINDING, COMPETITIVE; FEMALE; HEART ATRIA; KINETICS; MALE; PROPANOLAMINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; TRITIUM;

EID: 0031594650     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701609     Document Type: Article

References (49)

1. 3-Adrenoceptors and atypical β-adrenoceptors. Med. Res. Rev., 48, 663-729.
2. 2-selective adrenoceptor antagonist (ICI 118,551). J. Cardiovasc. Pharmacol., 5, 430-437.
3. BOND, R.A. & LEFKOWITZ, R.J. (1996). The third beta is not the charm. J. Clin. Invest., 93, 241.
4. 3-adrenoceptor. Br. J. Pharmacol., 112, 911-919.
5. CARLSSON, E., ÅBLAD, B., BRÄNDSTRÖM, A. & CARLSSON, B. (1972). Differentiated blockade of the chronotropic effects of various adrenergic stimuli in the cat heart. Life Sci., 11, 953-958.
6. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
7. 3-adrenoceptors in intact brown adipocytes of the rat. Br. J. Pharmacol., 114, 275-282.
8. DOLAN, J.A., MUENKEL, H.A., BURNS, M.G., PELLEGRINO, S.M., ERASER, C.M., PIETRI, F., STROSBERG, A.D., LARGIS, E.E., DUTIA, M.D., BLOOM, J.D., BASS, A.S., TANIKELLA, T.K., COBUZZI, A., LAI, F.M. & CLAUS, T.H. (1994). Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. J. Pharmacol. Exp. Ther., 269, 1000-1006.
9. 3 receptors. J. Pharmacol. Exp. Ther., 242, 257-262.
10. 2-adrenoceptors in the human atrioventricular conducting system: A comparison of patients with idiopathic dilated cardiomyopathy and ischemic heart disease. J. Mol. Cell. Cardiol., 26, 313-323.
11. 3-adrenergic receptor. J. Biol. Chem., 266, 20329-20336.
12. 3-adrenoceptor in the human heart. J. Clin. Invest., 98, 556-562.
13. GERMACK, R., STARZEC, A.B., VASSY, R. & PERRET, G. (1997). β-Adrenoceptor subtype expression and function in rat white adipocytes. Br. J. Pharmacol., 120, 201-210.
14. 3H]-tiotidine binding. Br. J. Pharmacol., 103, 1573-1579.
15. 2-adrenoceptor binding and functional response in right and left atria of rat heart. Naunyn-Schmiedeberg's Arch. Pharmacol., 330, 193-202.
16. KAUMANN, A.J. (1973). Adrenergic receptors in heart muscle. Two different mechanisms of β blockers as partial agonists. International Union of Biochemistry. Symposium 52. Acta Physiol. Latamer., 72, 63-82.
17. 2-adrenoceptors activated by (·)-adrenaline in rat sinoatrial node. Naunyn-Schmiedeberg's Arch. Pharmacol., 332, 406-409.
18. KAUMANN, A.J. (1989). Is there a third heart β-adrenoceptor? Trends Pharmacol. Sci., 10, 316-320.
19. KAUMANN, A.J. (1996). (-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor. Br. J. Pharmacol., 117, 619-622.
20. KAUMANN, A.J. (1997). Four β-adrenoceptor subtypes in mammalian heart. Trends Pharmacol. Sci., 18, 70-76.
21. KAUMANN, A.J. & LYNHAM, J.A. (1997). (-)-GP12177A stimulates cyclic AMP-dependent protein kinase in rat atria through an atypical β-adrenoceptor. Br. J. Pharmacol., 120, 1187-1189.
22. 4 receptor population in piglet right atrium: functional relevance. Br. J. Pharmacol., 115, 933-936.
23. 2-adrenoceptors. Pharmacol. Commun., 6, 215-222.
24. 3-adrenoceptors and is coupled to a cyclic AMP-dependent pathway in rat and human myocardium. Br. J. Pharmacol., 120, 102P.
25. 3-adrenoceptor in the rat. Br. J. Pharmacol., 118, 2085-2098.
26. KAUMANN, A.J. & MOLENAAR, P. (1997). Modulation of human cardiac function through 4 β-adrenoceptor populations. Naunyn-Schmiedeberg's Arch. Pharmacol., 355, 667-681.
27. KAUMANN, A.J., MORRIS, T.H. & BIRNBAUMER, L. (1979). A comparison of the influence of N-isopropyl and N-tert butyl substituents on the affinity of ligands for sinoatrial β-adrenoceptors in rat atria and β-adrenoceptors coupled to the adenylyl cyclase in kitten ventricle. Naunyn-Schmiedeberg's Arch. Pharmacol., 307, 1-8.
28. LEFKOWITZ, R.J., DE LEAN, A., HOFFMAN, B.B., STADEL, J.M., KENT, R., MICHEL, R. & LIMBIRD, L. (1981). Molecular pharmacology of adenylate cyclase-coupled α- and β-adrenergic receptors. Adv. Cyclic Nucleotide Res., 14, 145-161.
29. LEFKOWITZ, R.J., MULLIKIN, D. & CARON, M.G. (1976). Regulation of β-adrenergic receptors by guanyl-5′-yl imidodiphosphate and other purine nucleotides. J. Biol. Chem., 251, 4686-4692.
30. 3H]-ICI 118,551 and blocking potency of ICI 118,551. Naunyn-Schmiedeberg's Arch. Pharmacol., 331, 40-51.
31. 3-adrenergic receptors: Differential agonist actuation of recombinant receptors in Chinese hamster ovary cells. Mol. Pharmacol., 42, 634-637.
32. LOWRY, O.H., ROSENBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275.
33. MAGUIRE, M.E., VAN ARSDALE, P.M. & GILMAN, A.G. (1976). An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor. Mol. Pharmacol., 12, 335-339.
34. 3-adrenoceptors, mediate the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat. Br. J. Pharmacol., 117, 943-949.
35. 1-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 1-10.
36. MINNEMAN, K.P., HEDBERG, A. & MOLINOFF, P.B. (1979a). Comparison of beta adrenergic receptor subtypes in mammalian tissues. J. Pharmacol. Exp. Ther., 211, 502-508.
37. MINNEMAN, K.P., HEGSTRAND, L.R. & MOLINOFF, P.B. (1979b). Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol. Pharmacol., 16, 34-46.
38. 125]cyanopindolol binding in guinea-pig heart: characteristics of non-β-adrenoceptor related binding in cardiac pacemaker and conducting regions. Neurosci. Lett., 136, 118-122.
39. 3-adrenoceptors. Br. J. Pharmacol., 120, 165-176.
40. MUZZIN, P., REVELLI, J.P., KUHNE, F., GOCAYNE, J.D., MCCOMBIE, W.R., VENTER, J.C., GLACOBINO, J.-P. & FRASER, C.M. (1991). An adipose tissue-specific β-adrenergic receptor. Molecular cloning and down-regulation in obesity. J. Biol. Chem., 266, 24053-24058.
41. 3H]-CGP 12177A for resolving subtype-selectivity of competitive ligands. Naunyn-Schmiedeberg's Arch. Pharmacol., 336, 519-525.
42. 2-selective agonist procaterol of vascular and atrial preparations with different functional β-adrenoceptor populations. Br. J. Pharmacol., 84, 227-235.
43. 2-adrenoceptors. J. Auton. Pharmacol., 15, 239-255.
44. SARSERO, D., MOLENAAR, P. & KAUMANN, A.J. (1996a). The human cardiac atypical β-adrenoceptor stimulates a cyclic AMP-dependent pathway. J. Mol. Cell. Cardiol., 28, A274.
45. 4-adrenoceptor" causes positive inotropic effects and hastens relaxation in human atrium and ventricle through a cAMP dependent pathway. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol., 3, 38.
46. 3H]-CGP 12177A labels the atypical β-adrenoceptor (βAR) in rat atrium. The Pharmacologist, 39 (abstract 104), p 39.
47. STAEHELIN, M., SIMONS, P., JAEGGI, K. & WIGGER, H. (1983). CGP-12177. A hydrophilic β-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J. Biol. Chem., 258, 3496-3502.
48. 3-adrenoceptors in man. Q. J. Med., 86, 255-261.
49. WALTER, M., LEMOINE, H. & KAUMANN, A.J. (1984). Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of β-adrenoceptor subtypes in the dissociation between blockade and stimulation. Naunyn-Schmiedeberg's Arch. Pharmacol., 327, 159-175.